Casdin Capital, LLC Century Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 5,190,506 shares of IPSC stock, worth $8.3 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
5,190,506
Previous 3,206,380
61.88%
Holding current value
$8.3 Million
Previous $8.18 Million
61.88%
% of portfolio
1.14%
Previous 0.71%
Shares
2 transactions
Others Institutions Holding IPSC
# of Institutions
62Shares Held
37MCall Options Held
7KPut Options Held
300-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$8.66 Million2.82% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$8.62 Million1.51% of portfolio
-
Boxer Capital, LLC San Diego, CA4.9MShares$7.84 Million0.69% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$4.63 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$2.77 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $94.2M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...